AI in Endoscopy Market Size, Share and Growth Outlook, 2026

AI in Endoscopy Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global AI in Endoscopy Market size is forecast to increase from $599.65 Million in 2026 to $4457.82 Million in 2034 at a CAGR of 28.5% between 2026 and 2034.

The AI in Endoscopy market report provides detailed analysis and outlook of AI in Endoscopy segments including By Component (Hardware Systems, Software Solutions, Operational and Maintenance Services), By Application (Gastrointestinal Endoscopy, Urological Endoscopy, Respiratory, Laparoscopic Surgery), By Modality (On-Premise, Cloud-Based ), By Core Functionality (Computer-Aided Detection (CADe), Computer-Aided Diagnosis, Real-time Quality & Workflow Support, Training and Surgical Simulation), By End-User (Hospitals and Emergency Care Units, Ambulatory Surgical Centers (ASCs), Specialized Diagnostic & Gastrointestinal Clinics) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

AI in Endoscopy Industry Overview

The AI in Endoscopy industry is rapidly transforming gastrointestinal diagnostics through the integration of artificial intelligence into endoscopic imaging, lesion detection, and clinical workflow optimization. Healthcare providers are increasingly adopting AI-powered solutions to improve diagnostic accuracy, reduce missed lesions, and standardize procedural quality across healthcare facilities. Advances in real-time image analysis, cloud-enabled software deployment, and regulatory recognition are accelerating the integration of AI into routine endoscopic practice, positioning artificial intelligence as a critical component of next-generation gastrointestinal care.

Clinical Adoption and Real-Time Diagnostic Support Driving Market Growth

The deployment of AI-powered diagnostic support systems in clinical settings is expanding the practical application of artificial intelligence in endoscopy. Ainex Corporation strengthened its market presence through the implementation of its ENAD diagnostic support software at H+ Yangji Hospital in Seoul. The platform provides real-time gastrointestinal lesion detection during endoscopic procedures, helping clinicians identify abnormalities with greater consistency. The technology also received recognition as an innovative product by the Korean Public Procurement Service, reflecting growing institutional support for AI-enabled diagnostic solutions. Such deployments demonstrate increasing confidence among healthcare providers in utilizing artificial intelligence to enhance procedural outcomes and improve gastrointestinal disease detection.

Global Integration of AI Technologies into Endoscopic Platforms

Leading endoscopy manufacturers are increasingly embedding artificial intelligence into their core product ecosystems. Olympus announced the integration of a Korean-developed medical AI solution into its gastrointestinal endoscopy systems, representing a strategic shift toward incorporating regional AI innovation into globally deployed platforms. At the same time, manufacturers including Olympus and Medtronic are expanding the use of second-observer AI software within existing endoscopy towers. These solutions continuously analyze live endoscopic video feeds to assist physicians in identifying suspicious lesions that may otherwise be overlooked. The growing adoption of cloud and edge deployment models further enables software updates across multiple healthcare facilities, allowing hospitals to enhance lesion detection performance without replacing existing hardware infrastructure.

Clinical Validation and Regulatory Momentum Strengthening Adoption

Strong clinical evidence and regulatory support are reinforcing confidence in AI-assisted endoscopy technologies. A large-scale meta-analysis involving more than 17,000 patients demonstrated that AI-assisted upper gastrointestinal endoscopy significantly reduces blind spots and missed diagnoses during gastroscopy while achieving exceptionally high diagnostic sensitivity and specificity. Regulatory progress has also accelerated industry development, highlighted by FDA Breakthrough Device Designation granted to AI Medical Service Inc. for its AI-powered endoscopic platform. The system analyzes real-time video streams using algorithms trained on biopsy-proven clinical data to assist in the detection of cancerous, benign, and normal lesions throughout the gastrointestinal tract. These advancements are driving broader adoption of AI-enhanced endoscopic diagnostics across healthcare systems worldwide.

AI in Endoscopy Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global AI in Endoscopy market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Olympus Corporation, Medtronic plc, Fujifilm Holdings Corporation, Boston Scientific Corporation, PENTAX Medical, Intuitive Surgical, Ambu A/S, Iterative Scopes, NEC Corporation, Wision AI. The AI in Endoscopy market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the AI in Endoscopy industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth AI in Endoscopy Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by AI in Endoscopy companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional AI in Endoscopy markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

AI in Endoscopy Market Competitive Benchmarking and Company Analysis

Leading companies in AI in Endoscopy industry include- Olympus Corporation, Medtronic plc, Fujifilm Holdings Corporation, Boston Scientific Corporation, PENTAX Medical, Intuitive Surgical, Ambu A/S, Iterative Scopes, NEC Corporation, Wision AI. The AI in Endoscopy market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US AI in Endoscopy Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the AI in Endoscopy market remains one of the strongest-performing segments in the country.
The US AI in Endoscopy Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US AI in Endoscopy market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across AI in Endoscopy industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian AI in Endoscopy markets

Canada's strong AI in Endoscopy sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian AI in Endoscopy market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany AI in Endoscopy Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest AI in Endoscopy market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of AI in Endoscopy population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany AI in Endoscopy industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the AI in Endoscopy market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support AI in Endoscopy sales through 2034

France AI in Endoscopy companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK AI in Endoscopy Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of AI in Endoscopy distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China AI in Endoscopy Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China AI in Endoscopy market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of AI in Endoscopy industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese AI in Endoscopy industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India AI in Endoscopy Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian AI in Endoscopy market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil AI in Endoscopy market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa AI in Endoscopy Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

AI in Endoscopy Market Segmentation

By Component
Hardware Systems
Software Solutions
Operational and Maintenance Services
By Application
Gastrointestinal Endoscopy
Urological Endoscopy
Respiratory
Laparoscopic Surgery
By Modality
On-Premise
Cloud-Based
By Core Functionality
Computer-Aided Detection (CADe)
Computer-Aided Diagnosis
Real-time Quality & Workflow Support
Training and Surgical Simulation
By End-User
Hospitals and Emergency Care Units
Ambulatory Surgical Centers (ASCs)
Specialized Diagnostic & Gastrointestinal Clinics

Top Companies in AI in Endoscopy Industry

Olympus Corporation
Medtronic plc
Fujifilm Holdings Corporation
Boston Scientific Corporation
PENTAX Medical
Intuitive Surgical
Ambu A/S
Iterative Scopes
NEC Corporation
Wision AI

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Biotech and Fermented Ingredient Integration to gain rapid penetration

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025